✦ LIBER ✦

Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer

✍ Scribed by Chad A. Hamilton; G. Larry Maxwell; Mildred R. Chernofsky; Sarah A. Bernstein; John H. Farley; G. Scott Rose

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of bevacizumab to palliate sympt

✍ T. Michael Numnum; Rodney P. Rocconi; Jenny Whitworth; Mack N. Barnes 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Intraperitoneal Pressures and Clinical P

✍ Walter H. Gotlieb; Baruch Feldman; Orit Feldman-Moran; Nissim Zmira; Doron Kreiz 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Evaluation of low-dose intraperitoneal i

✍ Dineo Khabele; Carolyn D Runowicz; Abbie L Fields; Patrick S Anderson; Gary L Go 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 57 KB

A pilot study of combination intraperito

✍ Zhao, Jing; Chen, Xinxiao; Zhang, Aimu; Xu, Feng; Hu, Meilong; Xie, Congying; Xu 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 313 KB

Intraperitoneal VEGF Inhibition Using Be

✍ Kobold, S.; Hegewisch-Becker, S.; Oechsle, K.; Jordan, K.; Bokemeyer, C.; Atanac 📂 Article 📅 2009 🏛 Alphamed Press 🌐 English ⚖ 97 KB

Different sequential approaches of cytor

✍ Ba, Mingchen; Long, Hui; Zhang, Xiangliang; Tang, Yunqiang; Wu, Yinbing; Yu, Fei 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 444 KB